SCHEMBL5701145

SCHEMBL5701145

CN(C)c1ccc(C=CC2=CC(=Cc3sc4ccccc4[n+]3C)CC(C)(C)C2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ INSR P06213 15/20 0.61
▸ MAPT P10636 3/20 0.55
▸ HTT P42858 3/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.55
▸ POLB P06746 2/20 0.55
▸ NSD2 O96028 2/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ ALDH1A1 P00352 2/20 0.47
▸ PKM P14618 2/20 0.47
▸ NPC1 O15118 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ APP P05067 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5701141 1.00 INSR (0.61) INSRMAPTHTTNPSR1POLB
Perchlorate SCHEMBL1532917 0.97 HTT (0.60) INSRMAPTHTTNPSR1POLB
Perchlorate SCHEMBL1532916 0.97 HTT (0.60) INSRMAPTHTTNPSR1POLB
Perchlorate SCHEMBL3746611 0.92 HTT (0.55) INSRMAPTHTTNPSR1POLB
SCHEMBL10036133 0.89 INSR (0.64) INSRMAPTHTTNPSR1POLB
SCHEMBL15942186 0.89 INSR (0.64) INSRMAPTHTTNPSR1POLB
SCHEMBL15704577 0.82 POLB (0.54) INSRMAPTHTTNPSR1POLB
SCHEMBL14984211 0.78 INSR (1.00) INSRMAPTHTTNPSR1POLB
Hydrochloric Acid SCHEMBL8386848 0.77 INSR (0.97) INSRMAPTHTTNPSR1POLB
Iodide SCHEMBL8387880 0.77 INSR (0.97) INSRMAPTHTTNPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8834846-B2 Fluorescent NIRF activatable probes for disease detection BRUKER BIOSPIN CORPORATION (US) 2014-09-16 — — US disclosed
WO-2012107701-A1 SUNLIGHT MODULATING MATERIAL PHOTOFUEL (FR) 2012-08-16 — — WO disclosed
US-20110293529-A1 FLUORESCENT NIRF ACTIVATABLE PROBES FOR DISEASE DETECTION BRUKER BIOSPIN CORPORATION 2011-12-01 — — US disclosed
US-7151623-B2 Holographic data-storage medium TESA SCRIBOS GMBH (DE) 2006-12-19 — — US disclosed
EP-1395985-B1 HOLOGRAPHIC DATA-STORAGE MEDIUM TESA SCRIBOS GMBH (DE) 2006-09-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110293529-A1 FLUORESCENT NIRF ACTIVATABLE PROBES FOR DISEASE DETECTION CTSF, ENGASE, DNTT INSR 2910/4885MAPT 1543/4885HTT 1794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback